{{Rsnum
|rsid=694539
|Chromosome=11
|position=114262697
|Orientation=minus
|GMAF=0.2406
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LOC101928916
|Gene_s=LOC101928916
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 30.1 | 66.4
| HCB | 10.3 | 47.8 | 41.9
| JPT | 8.8 | 46.9 | 44.2
| YRI | 5.4 | 40.1 | 54.4
| ASW | 8.8 | 29.8 | 61.4
| CHB | 10.3 | 47.8 | 41.9
| CHD | 19.3 | 42.2 | 38.5
| GIH | 12.9 | 41.6 | 45.5
| LWK | 3.6 | 42.7 | 53.6
| MEX | 1.7 | 41.4 | 56.9
| MKK | 7.7 | 39.1 | 53.2
| TSI | 1.0 | 37.3 | 61.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21791160
|Title=Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levels
}}

{{PMID Auto
|PMID=15849667
|Title=A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project.
|OA=1
}}

{{PMID Auto
|PMID=17412799
|Title=Genetic and environmental influences on plasma homocysteine: results from a Danish twin study.
}}

{{PMID Auto
|PMID=18553462
|Title=Nicotinamide N-methyl transferase (NNMT) gene polymorphisms and risk for spina bifida.
|OA=1
}}

{{PMID Auto
|PMID=24004542
|Title=Association of nicotinamide-N-methyltransferase (NNMT) gene rs694539 variant with bipolar disorder
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}